Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Petros Pharmaceuticals Announces Completion Of Human Factors Study, To Facilitate Patient's Access To Its Erectile Dysfunction Drug, Stendra Associated With The Company's Intended FDA Application For Prescription To OTC Switch

Author: Benzinga Newsdesk | December 12, 2023 11:04am

Human Factor Study represents important component of FDA requirements for technology to pave way for STENDRA OTC approval

Posted In: PTPI